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Background: Acute kidney injury (AKI) after cardiac surgery is associated with an increased risk of mortality.
Preoperative risk scores can identify patients at risk for AKI and facilitate preventive strategies. Currently, validated
risk scores are used to predict AKI requiring dialysis (AKI-D); less is known about whether these tools predict less
severe forms of AKI.
Objective: To evaluate the Cleveland Clinic scoring tool in predicting both AKI-D and less severe stages of AKI in
patients after cardiac surgery in a Canadian tertiary care center.
Design: Retrospective case–control study.
Setting: Regina Qu’Appelle Health Region (RQHR) from 2007 to 2011.
Patients: Patients who underwent cardiac surgery and developed postoperative kidney injury (n = 2316).
Measurements: Data on risk factors for AKI and outcomes of cardiac surgery were collected from a retrospective
chart review.
Methods: The primary outcome was AKI, defined as Stage 1 (increase in serum creatinine 1.5-1.9 X baseline within
5 days), Stage 2 (increase 2.0-2.9 X baseline), or Stage 3 (increase 3.0 X baseline or more OR initiation of dialysis
during hospital stay). We assessed the performance of a modified version of the Cleveland Clinic tool using receiver
operating curve analyses.
Results: The incidence of AKI was 6.1% (Stage 1), 2.6% (Stage 2), and 5.8% (Stage 3). The area under the curve
(AUC) for the Cleveland score was 0.61 (95% CI: 0.56 to 0.65; p < 0.001) for Stage 1, 0.61 (95% CI: 0.54 to 0.68;
p < 0.01) for Stage 2, and 0.78 (95% CI: 0.74 to 0.82; p < 0.001) for Stage 3. Greater level of risk on the Cleveland tool
was associated with a higher risk of Stage 3 AKI.
Limitations: Lack of prospective validation.
Conclusions: The modified Cleveland Clinic tool was valid in identifying patients with severe stages of AKI but did
not have strong discrimination for early AKI stages.
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Contexte: L’insuffisance rénale aiguë (IRA) survenant après une chirurgie cardiaque est liée à un risque accru de
mortalité. Divers outils d’évaluation du risque préopératoire permettent de dépister les patients à risque d’IRA,
facilitant ainsi les stratégies de prévention. Présentement, les scores de risque validés sont utilisés pour prédire une
IRA nécessitant une dialyse (IRA-D); nous avons toutefois peu d’information sur l’utilité de ces outils d’évaluation
pour prédire des formes moins sévères d’IRA.
Objectif de l’étude: Déterminer la valeur prédictive de l’outil d’évaluation de la Cleveland Clinic, en ce qui
concerne l’IRA-D et des formes moins sévères d’IRA, chez des patients en phase postopératoire cardiaque, dans un
établissement de soins tertiaires canadien.
Type d’étude: Étude cas-témoins.
Contexte: Regina Qu’Appelle Health Region (RQHR) pour la période de 2007 à 2011.
Patients: Échantillon de patients ayant subi une chirurgie cardiaque, et ayant développé une IRA postopératoire
(n = 2316).
Mesures: Les données concernant les facteurs de risque d’IRA, et les résultats de la chirurgie cardiaque ont été
colligés à partir d’un examen rétrospectif des dossiers.
Méthode: La première complication rapportée était l’IRA : de stade 1 (avec élévation du taux de créatininémie de
1,5 -1,9 X par rapport à la valeur de référence, à l’intérieur de 5 jours); de stade 2 (élévation de 2,0-2,9 X la valeur de
référence), ou de stade 3 (élévation minimale de 3 X la valeur de référence ou dialyse initiée pendant le séjour à
l’hôpital). Nous avons évalué la performance d’une version modifiée de l’outil d’évaluation de la Cleveland Clinic en
analysant la courbe ROC (receiver operating curve).
Résultats: La fréquence d’IRA était de 6,1% (stade 1), 2,6% (stade 2), et de 5,8% (stade 3). L’aire sous la courbe, pour
le score de Cleveland était de 0,61 (IC 95%: de 0,56 à 0,65; p < 0.001) pour l’IRA de stade 1, de 0,61 (IC 95%; de 0,54
à 0,68; p < 0.01) pour le stade 2, et de 0,78 (IC 95%: de 0,74 à 0,82; p < 0.001) pour le stade 3. Un risque accru avec
l’outil d’évaluation de la Cleveland Clinic était lié à un risque accru d’IRA de stade 3.
Limites de l’étude: Absence de validation prospective.
Conclusions: La version modifiée de l’outil d’évaluation de la Cleveland Clinic dépistait adéquatement les patients
atteints de l’IRA dans ses formes sévères, mais ne permet aucune distinction claire pour ce qui est des stades moins
sévères de l’IRA.What was known before
The Cleveland Clinic score has consistently had the
highest discrimination when compared to other risk
scores that predict AKI requiring dialysis (AKI-D), and it
has been validated in multiple cohorts for AKI-D. How-
ever, it has not been validated in a Canadian cohort for
less severe forms of AKI.
What this adds
We demonstrated in a Canadian cohort that the Cleveland
Clinic score was valid in predicting severe AKI (Stage 3),
but less successful in predicting patients with less severe
forms of AKI (Stage 1 and Stage 2).
Background
Acute kidney injury (AKI) after cardiac surgery is a ser-
ious complication due to its association with elevated
mortality [1-5]. Depending on the definition, up to 30%
of cardiac surgery patients develop some form of AKI
post-surgery [2,5-11], and 1-5% of patients develop the
most severe form of kidney injury: AKI requiring dialysis(AKI-D) [2,8,11,12]. Mortality following AKI-D has been
reported to be greater than 50%, and in some cases, as
high as 80% [1,10,13-15]. In contrast, mortality associated
with cardiac surgery alone ranges from 2 to 8% [8,16,17].
Even mild forms of AKI can impact short- and long-term
morbidity and mortality [7,10,18-21]. Minor (0–44.2 μmol/
L) postoperative increases in serum creatinine (SCr) from
baseline can increase the risk of 30-day mortality 3-fold
[10]; and larger SCr increases (≥44.2 μmol/L) were associ-
ated with a >18-fold elevation [10]. Less severe forms of
AKI after cardiac surgery are also associated with an in-
creased risk of other adverse outcomes, such as progression
of chronic kidney disease (CKD) [22], increased postopera-
tive length of stay [23], and increased risk of 30-day hospital
readmission [24]. The short- and long-term outcomes asso-
ciated with less severe forms of AKI indicate that preven-
tion and treatment measures are desperately needed.
Currently, there is no clear evidence for an effective
preventive or therapeutic pharmaceutical agent for AKI
[1,3,8,25,26]. Preoperative risk stratification can contrib-
ute to informed decision making, increased awareness
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optimization, and future research studies [27]. There are
a few externally valid scoring tools for risk stratification
for AKI-D [8]. Using major AKI-D risk factors, Thakar
et al. [16] developed the Cleveland Clinic scoring tool in
a large cohort of patients (n = 15,838) to identify patients
at risk of developing AKI-D after open-heart surgery. Of
the available AKI-D scoring tools, multiple comparison
studies have found that the Cleveland Clinic score has
the highest discriminative power, and it has performed
well in some external cohorts [6,27-29]. However, a key
limitation of this risk score is that it does not predict
milder forms of AKI [14,30,31], which still have signifi-
cant short- and long-term health effects.
The purpose of this study was to assess the perform-
ance of the Cleveland Clinic scoring tool in predicting
all stages of AKI in a Canadian tertiary care center pro-
viding cardiac surgery.
Methods
Data collection and study cohort
We conducted a retrospective chart review of all pa-
tients who underwent cardiac surgery from 2007 to 2011
in the RQHR (n = 2343). The data for all variables except
serum creatinine were obtained from a database pro-
duced by the health records department who previously
coded and entered the data from patient hospital charts.
Data for serum creatinine was obtained using an elec-
tronic repository that houses all lab data in the hospital.
We used the Medical Information Quality System (MIQS)
to identify patients who required intermittent hemodialysis
if there were any discrepancies in the data.
We collected data on the following variables that were
predictors of AKI in the Cleveland Clinic scoring tool
[16]: gender; comorbidities including congestive heart
failure (CHF), type 1 diabetes, and chronic obstructive
pulmonary disease (COPD); cardiac indicators including
left ventricular ejection fraction (LVEF) <35%, preopera-
tive use of an intra-aortic balloon pump (IABP), and his-
tory of previous cardiac surgery; type of current cardiac
surgery; and preoperative creatinine (μmol/L). We were
not able to obtain data on insulin use in patients with
diabetes; therefore we focused only on type 1 diabetics.
We also did not have information on medication use in
COPD so all patients with this diagnosis were included.
The types of cardiac surgery included coronary artery
bypass graft (CABG), aortic valve repair or replacement
(AVR), mitral valve repair or replacement (MVR), tricus-
pid valve repair or replacement (TVR), and combinations
of CABG and AVR, MVR and TVR, as well as other
cardiac surgeries such as ventricular aneurysm repair,
pericardiectomy, etc. Emergent surgery data was not used
because it was not consistently or accurately recorded in
the patients' charts.In addition, we collected data on other preoperative
variables (age, BMI), perioperative variables [operating
room time (open to close; minutes), operation time (entry
to exit; minutes), clamp time (minutes), pump time (mi-
nutes), number of bypass grafts], and postoperative vari-
ables [length of stay (days) and dialysis modality if required
(hemodialysis, continuous, peritoneal dialysis)]. For pre-
operative creatinine, we used data from the sample that
was reported by the lab at the time closest to the start of
the surgery (up to and within 5 minutes after the start of
surgery). This included lab samples taken up to 3 months
prior to the surgery in rare cases. For postoperative cre-
atinine, we collected data from the highest creatinine sam-
ple on each postoperative day for five consecutive days,
and also the highest sample on the final day of hospital stay
if the patient stayed more than five days. If there were no
data on a given postoperative day, it was left blank.
Outcomes
Our primary outcome was AKI Stage 1, Stage 2 or Stage
3. Stage 1 was defined as an increase in serum creatinine
1.5-1.9 X baseline within 5 days. Stage 2 was an increase
in serum creatinine 2.0-2.9 X baseline within 5 days, and
Stage 3 was an increase in serum creatinine 3.0 X base-
line or more OR initiation of dialysis anytime during
hospital stay. The groups were mutually exclusive. Due
to limitations in data availability up to 7 days and urine
output, we were not able to use the formal KDIGO cri-
teria for AKI [32].
Cleveland clinic score
To evaluate the use of the scoring tool, we calculated a
score for each patient based on the general method de-
scribed previously (Thakar et al. [16]; Additional file 1).
As noted above, we were limited to using type 1 diabetes
instead of insulin-requiring diabetes, and were unable to
include emergency surgery in the scoring tool. There-
fore, the minimum score for a patient was 0 and the
maximum was 15 (instead of 17).
Statistical analyses
Descriptive statistics for categorical variables were reported
as frequency (percentage), whereas continuous variables
were reported as means (standard deviation). Categorical
variables were compared between AKI Stages 1–3 using
chi-square tests, and continuous variables were compared
using one-way ANOVAs. Logistic regression models and
receiver operator curve analyses were used to calculate
area under the curve (AUC) for the prediction of AKI
Stage 1, 2 and 3 using the Cleveland score. All statistical
tests were 2-sided, with alpha level set at 0.05 for statistical
significance. Statistical analyses were performed using SPSS
Version 17.0. The Regina Qu’Appelle Health Region and
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through a harmonized review approved the study.
Results
A total of 2343 patients had cardiac surgery performed
between 2007 and 2011. Two patients did not have
complete creatinine data, and twenty-five patients were
excluded from the data due to a history of requiring dialy-
sis (either hemodialysis or peritoneal) prior to surgery,
leaving a final sample of 2316 patients.
The incidence of AKI was 6.1% (n = 142) in Stage 1,
2.6% (n = 60) in Stage 2, and 5.8% (n = 134) in Stage 3.
Of the total 134 Stage 3 patients, 125 (5.4% of total)
patients required dialysis during their hospital stay.
Seventy-six of the 125 patients (60.8%) received in-patient
hemodialysis, 45 (36%) received continuous renal replace-
ment therapy, and 1 (1%) patient received peritoneal dialy-
sis; for 4 others (3.2%), the type of dialysis was not
recorded.
We compared patients without AKI to patients with
AKI Stages on all potential risk factors using chi-square
analyses and one-way ANOVA’s as appropriate. Patients
in the four groups were similar in terms of BMI, and the
number of bypass grafts (Table 1). A history of previous
cardiac surgery, preoperative use of an IABP, presence of
CHF, type of surgery, as well as intraoperative risk factors
such as longer clamp time and pump time were associated
with more severe AKI (Table 1). The overall relationship
between diabetes and AKI Stage was significant (p = 0.01),
but this was largely driven by a large percentage of pa-
tients in Stage 2 with type 2 diabetes; the p-value for type
1 diabetes alone was not significant (p = 0.7). Patients with
increased severity of AKI had a significantly longer length
of stay in hospital (32 vs. 14 days; Table 2) and were much
more likely to die in hospital (47.8% vs. 2.5%).
Cleveland clinic scoring tool
There was a significant overall difference between the
KDIGO Stages in the modified Cleveland Clinic score;
p < 0.001). The mean scores were significantly different
between all groups except Stage 1 vs. Stage 2 (p < 0.001;
Table 3). Like Thakar et al. and Englberger et al. [6,16],
we grouped the Cleveland score into four risk categories:
low risk (0–2), intermediate risk (3–5), high risk (6–8) and
very high risk (≥9). The frequency of patients in each risk
category is presented in Table 3. There was a significant
relationship between Cleveland Clinic Risk Score Category
and AKI Stage with a greater percentage of patients in
higher AKI Stages for those classified as higher risk of
AKI on the Cleveland tool.
To test the validation of the Cleveland Clinic score in
our population, we generated receiver operating charac-
teristics curves for predicting AKI Stages 1, 2, and 3 using
the Cleveland Clinic score. The area under the curve(AUC) for the Cleveland score was 0.61 (95% CI: 0.56 to
0.65; p < 0.001) for Stage 1, 0.61 (95% CI: 0.54 to 0.68;
p < 0.01) for Stage 2, and 0.78 (95% CI: 0.74 to 0.82; p <
0.001) for Stage 3 (Figure 1). We also were interested in
whether combining Stage 1 and Stage 2 would improve
the AUC of the model; however, the value remained the
same (0.61, 95% CI: 0.57 to 0.65; p < 0.001).
We did a post-hoc analysis of calibration and found the
model to have good calibration for prediction of Stage 3
(p = 0.84), moderate calibration for Stage 1 (p = 0.29), and
poor discrimination for Stage 2 (p = 0.08), with higher
p-values indicating better calibration. However, given
that calibration is very sensitive to sample size, the re-
sults should be interpreted with caution.
Discussion
We used the Cleveland Clinic scoring tool to predict dif-
ferent stages of AKI within 5 days of cardiac surgery in pa-
tients treated between 2007 and 2011 in the RQHR. Like
previous studies [6,27-29], we found that the Cleveland
Clinic tool performed well in discriminating patients who
required dialysis (Stage 3) from patients without any kid-
ney injury (no AKI). However, the score exhibited much
weaker discrimination for less severe AKI (Stages 1 and
2). To our knowledge, the present study is the first study
to evaluate the Cleveland Clinic score for less severe
AKI in a Canadian cohort.
We found that the AUC for the Cleveland Clinic score
for patients requiring dialysis was 0.78, which is margin-
ally lower than the values seen in previous studies with
values consistently >0.80 [6,27-29]. A previous study in
Germany [33] found that the Cleveland tool had an
AUC of 0.66, but variable definitions for risk factors and
limitations in their risk factor data may have resulted in
the low AUC value. To our knowledge, two previous
studies have used the Cleveland Clinic score in AKI pa-
tients not requiring dialysis [6,27]. Englberger et al. [6]
defined severe AKI as an increase in SCr to >2.0 mg/dL
(>176.8 μmol/L) and a 2-fold increase compared to base-
line, whereas Kiers et al. used the RIFLE criteria to identify
patients with ≥50% relative increase in SCr compared to
baseline [27]. In both studies, the Cleveland Clinic score
still had the highest AUC compared to other scoring tools,
but the AUC for AKI not requiring dialysis was lower
than the AUC for AKI-D [6,27]. We found that the
Cleveland Clinic score had lower discriminative power
for AKI Stages 1 and 2 (0.61 for both) compared to these
previous studies.
Several factors may have contributed to the lower
AUCs in our cohort. We hypothesize that the difference
in AUC is likely due to true differences in the study popu-
lation and center-specific practices, rather than limitations
in the definitions of the predictors and outcomes. Our pa-
tients may have been in better preoperative health than
Table 1 Preoperative and perioperative risk variables associated with KDIGO stages 1-3








Preoperative continuous Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years) 66.75 (11.01) 69.40* (10.96) 70.27 (10.30) 69.81* (12.43)
BMI 29.74 (7.97) 30.98 (5.87) 30.54 (5.61) 30.23 (5.35)
Preoperative creatinine (μmol/L) 95.48 (32.16) 101.25 (36.40) 95.28 (20.19) 152.07 (121.10)*,&,#
Preoperative categorical N (%) N (%) N (%) N (%) p-value
Gender 0.9
Female (n = 585) 494 (24.9%) 39 (27.5%) 17 (28.3%) 35 (26.1%)
Male (n = 1731) 1486 (75.1%) 103 (72.5%) 43 (71.7%) 99 (73.9%)
Preoperative intra-aortic balloon pump 0.02
Yes (n = 27) 18 (0.9%) 3 (2.1%) 1 (1.7%) 5 (3.7%)
No (n = 2289) 1962 (99.1%) 139 (97.9%) 59 (98.3%) 129 (96.3%)
Congestive heart failure <0.001
Yes (n = 256) 177 (8.9%) 23 (16.2%) 15 (25%) 41 (30.6%)
No (n = 2060) 1803 (91.1%) 119 (83.8%) 45 (75%) 93 (69.4%)
Ejection fraction <35% 0.8
Yes (n = 224) 197 (9.9%) 11 (7.7%) 5 (8.3%) 11 (8.2%)
sNo (n = 2092) 1783 (90.1%) 131 (92.3%) 55 (91.7%) 123 (91.8%)
Type of surgery <0.001
CABG only (n = 1509) 1344 (67.9%) 77 (54.2%) 25 (41.7%) 63 (47.0%)
Valve only (n = 251) 220 (11.1%) 11 (7.7%) 8 (13.3%) 12 (9.0%)
CABG + valve (n = 468) 341 (17.2%) 48 (33.8%) 24 (40.0%) 55 (41.0%)
Other cardiac surgery(n = 88) 75 (3.8%) 6 (4.2%) 3 (5.0%) 4 (3.0%)
Previous cardiac surgery <0.001
Yes (n = 178) 131 (6.6%) 21 (14.8%) 8 (13.3%) 18 (13.4%)
No (n = 2138) 1849 (93.4%) 121 (85.2%) 52 (86.7%) 116 (86.6%)
Diabetes mellitus^ 0.01
Type 1 (n = 22) 18 (0.9%) 2 (1.4%) 0 2 (1.5%)
Type 2 (n = 698) 569 (28.7%) 50 (35.2%) 28 (46.7%) 51 (38.1%)
None (n = 1596) 1393 (70.4%) 90 (63.4%) 32 (53.3%) 81 (60.4%)
Chronic obstructive pulmonary disease 0.2
Yes (n = 114) 90 (4.5%) 10 (7.0%) 4 (6.7%) 10 (7.5%)
No (n = 2202) 1890 (95.5%) 132 (93.0%) 56 (93.3%) 124 (92.5%)
Total 100% 100% 100% 100%
Perioperative continuous Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Cardiopulmonary bypass time
(entry to exit minutes)
279.79 (73.91) 314.45* (93.31) 316.45* (92.60) 340.02*,& (109.14)
Clamp time (minutes) 94.77 (36.63) 111.87* (40.65) 114.72* (48.14) 126.36*,& (55.70)
Pump time (minutes) 112.55 (47.95) 135.55* (51.30) 141.98* (66.01) 162.98*,& (78.01)
Number of bypass grafts 5.53 (1.87) 5.44 (2.07) 5.25 (2.49) 5.35 (2.21)
Abbreviations: AKI acute kidney injury, BMI body mass index, CABG coronary artery bypass graft, KDIGO, kidney disease: improving global outcomes, SD
standard deviation.
Note: Conversion factors for units: SCr in to μmol/L to mg/dL x0.0113.
*significantly different from No AKI (p < 0.05, Bonferonni).
&significant different from Stage 1 (p < 0.05, Bonferonni).
#significantly different from Stage 2 (p < 0.05, Bonferonni).
^p-value with type 1 diabetes only: p = 0.7.
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Table 2 Patient outcomes after cardiac surgery






N (%) N (%) N (%) N (%) p-value
Type of dialysis N/A N/A N/A N/A
Continuous Renal Replacement Therapy 45 (36%)
In-Patient Hemodialysis 75 (60%)
Peritoneal Dialysis 1 (0.8%)
Unknown 4 (3.2%)
Discharge destination
Died (n = 148)^ 50 (2.5%) 20 (14.1%) 14 (23.3%) 64 (47.8%)
Home (n = 1327) 1220 (61.6%) 66 (46.5%) 16 (26.7%) 25 (18.7%)
Support services (n = 598) 537 (27.1%) 32 (22.5%) 10 (16.7%) 19 (14.2%)
Inpatient facility (n = 204) 147 (7.4%) 20 (14.1%) 17 (28.3%) 20 (14.9%)
Long-term care facility (n = 31) 19 (1.0%) 4 (2.8%) 3 (5.0%) 5 (3.7%)
Other (n = 8) 7 (0.4%) 0 0 1 (0.7%)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) p-value
Length of stay (days) 14.02 (11.55) 23.83* (35.80) 24.97* (18.31) 32.96*,& (33.05) <0.001
Abbreviations: AKI acute kidney injury, KDIGO kidney disease: improving global outcomes, SD standard deviation.
^Mortality only: Χ2 (3) = 475.69, p < 0.001, Cramer’s V = 0.45.
*significantly different from No AKI (p < 0.05, Bonferroni).
&significantly different from Stage 1 (p < 0.05, Bonferroni).
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poorer preoperative cardiac function [6,16,27,28], similar
to the patients in the original Cleveland Clinic score de-
velopment study [16]. The Cleveland Clinic score was also
validated in a cohort with a higher proportion of non-
isolated CABG surgeries [16]. Isolated CABG surgery has
a lower incidence of AKI compared to valve and com-
bined surgeries [4,7], and this is reflected in the Cleveland
Clinic score as non-isolated CABG surgeries are assigned
higher point values [16]. The combination of healthier pa-
tients in our cohort and less complex surgeries than other
cohorts [6,28,33] may have resulted in lower discrimina-
tive power. The absence of data on whether the surgery
was emergent or not, one of the stronger contributors
to the Cleveland Clinic scoring tool [16], may also have
reduced the predictive power of the Cleveland score.
The way emergent surgery is recorded would also beTable 3 Relationship between KDIGO stage and risk categorie
No AKI (N = 1980) KDIGO stage
Overall mean (SD) risk score 1.61 (1.59) 2.34* (1.68)
Cleveland risk category N (%) N (%)
Low risk (0–2; n = 1659) 1503 (90.6%) 82 (4.9%)
Intermediate risk (3–5; n = 576) 429 (74.4%) 55 (9.5%)
High risk (6–8; n = 75) 47 (59.5%) 5 (6.3%)
Very high risk (≥9; n = 1) 1 (100%) 0
Abbreviations: AKI acute kidney injury, KDIGO kidney disease: improving global outc
*significantly different from No AKI (p < 0.05, Bonferonni).
&significantly different from Stage 1 (p < 0.05, Bonferonni).important as the outcomes of patients labeled as “emer-
gent” can be vastly different.
Unlike the original Cleveland Clinic score paper [16],
female gender, COPD, type 1 diabetes and LVEF <35%
were not significant predictors of AKI Stage in our co-
hort. As noted above, better preoperative health of our
cohort may be a contributing factor. In addition, there
was variation in the way LVEF was measured and re-
corded among clinicians at our center. Typically patients
with LVEF <20% are not operated on at our center.
Approximately half the LVEF data were coded as binary
(<35%, ≥35%) so we were unable to examine the distri-
bution of patients with LVEF levels and determine if our
population had more LVEF closer to 35% compared to
other studies. Therefore, selection bias may have con-
tributed to the lack of LVEF effect in our study. We had
a very low proportion of patients with type 1 diabetess of the Cleveland tool
1 (N = 142) KDIGO stage 2 (N = 60) KDIGO stage 3 (N = 134)
2.35* (1.66) 3.69*,& (2.07)
N (%) N (%)
32 (1.9%) 42 (2.5%)
25 (4.3%) 68 (11.8%)
3 (3.8%) 24 (30.4%)
0 0
omes, SD standard deviation.
Figure 1 Area under the curve for Cleveland score for patients with AKI stage 1 (Grey oval dash), stage 2 (Grey solid) and stage 3
(Grey circle dotted). The black line represents the line of identity, c statistic 0.50. Abbreviations: KDIGO, Kidney Disease: Improving
Global Outcomes.
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estimated the sample size for that predictor and reduced
our power. Also, Thakar [17] defined COPD as a history
of COPD requiring medications; we were not able to de-
termine from the records whether patients were medi-
cated or not. Moreover, COPD is used inconsistently as
a general descriptor of patients with breathing difficul-
ties or a history of smoking without requiring medical
tests prior to diagnosis. Thus, it is possible that our pa-
tients had a lower severity of COPD than other cohorts.
Almost half of all patients who progressed to Stage 3
AKI after cardiac surgery died, whereas 23.3% died in
Stage 2 and 14.1% in Stage 1. Therefore, even AKI Stages
1 and 2 are associated with a high degree of mortality.
Even though the numbers were small, 2.8% of patients in
Stage 1 and 5.0% in Stage 2 required long-term care facil-
ities. Patients in Stage 1 and 2 also stayed significantly lon-
ger in hospital than patients with no AKI. Therefore, our
data suggest that even early stages of AKI are associated
with considerable burden on the patient and the health
care system, warranting a need for preoperative risk as-
sessment. These results were similar to other studies, andfurther illustrate the need for prediction models that are
accurate in predicting earlier stages of AKI.
Ideally, a preoperative risk stratification tool would
identify high-risk patients so that prevention strategies
could be started earlier, which would improve quality of
care, patient management, and resource allocation. These
measures may include: avoiding nephrotoxic medications
whenever possible, optimizing fluid volume and perfusion
pressure, correcting electrolyte imbalances, monitoring in-
dicators of renal function such as SCr and urine output,
treating infection and oliguria quickly, preventing hyper-
glycemia, and considering alternatives to therapies that
may result in an elevated risk of kidney injury, such as
those involving traditional contrast agents [3,5,32,34,35].
Although several biomarkers have shown promise in de-
tecting AKI at 24 hours after surgery, intraoperative or
immediately postoperative detection remains elusive [1].
Conclusions
We have demonstrated the validity of the Cleveland Clinic
score for predicting risk of severe AKI (Stage 3) in a large,
diverse sample of Canadian patients undergoing cardiac
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tients into Stages 1 or 2. However, these earlier and
milder forms of AKI were still associated with outcomes
that have a considerable impact on health care expend-
iture, such as increased time in hospital, home care and
other support services, and time in rehabilitation step-
down units. AKI also greatly increases the risk of chronic
kidney disease and downstream end-stage renal disease.
Therefore, future research is needed to create alternative
risk scores that can accurately predict earlier stages of
AKI in order to develop interventions that may prevent
these adverse events.
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